Long-term Safety and Performance of Materialise's Patient-specific TMJ System.
← catalyst calendarNCT06951178 · readout ≤ 3,968 d
Sponsored by Materialise (industry) · MTLS.BR — their whole pipeline →.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
30estimated
Sites
1
Country
Denmark
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jun 2025 | estimated | When the study began enrolling |
| Primary completion | Jun 2037 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2037 | estimated | The whole study's end, after follow-up |
| First posted | 2025-04-30 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-04-30 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Temporomandibular Joint Disorders
Intervention
- Device: TMJ Total Arthroplasty System (TMJ System) — also filed as Temporomandibular joint reconstruction
Primary outcome
what the primary-completion date above is the date OFImplant success rate
measured 10-year follow-up post-implantation, with evaluations at Week 1, Week 4, Month 3, Month 6, Year 1, Year 2, Year 3, Year 5, and Year 10, or until device removal.
Permalink · MTLS.BR's whole pipeline · Catalyst calendar · Every registered study · What changed